Andrew Turitz's most recent trade in Teladoc Health Inc was a trade of 20,773 Common Stock done at an average price of $7.3 . Disclosure was reported to the exchange on Sept. 4, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Teladoc Health Inc | Andrew Turitz | EVP, CORPORATE DEVELOPMENT | 04 Sep 2024 | 20,773 | 20,773 (0%) | 0% | 7.3 | 150,812 | Common Stock | |
| Teladoc Health Inc | Andrew Turitz | EVP, CORPORATE DEVELOPMENT | 30 Aug 2024 | 3,100 | 18,602 | - | - | Restricted Stock Units | ||
| Teladoc Health Inc | Andrew Turitz | EVP, CORPORATE DEVELOPMENT | 30 Aug 2024 | 3,100 | 43,163 (0%) | 0% | - | Common Stock | ||
| Teladoc Health Inc | Andrew Turitz | EVP, CORPORATE DEVELOPMENT | 30 Aug 2024 | 1,617 | 41,546 (0%) | 0% | 7.2 | 11,584 | Common Stock | |
| Teladoc Health Inc | Andrew Turitz | EVP, CORPORATE DEVELOPMENT | 30 Aug 2024 | 1,348 | 2,696 | - | - | Restricted Stock Units | ||
| Teladoc Health Inc | Andrew Turitz | EVP, CORPORATE DEVELOPMENT | 30 Aug 2024 | 1,348 | 40,063 (0%) | 0% | - | Common Stock | ||
| Teladoc Health Inc | Andrew Turitz | EVP, CORPORATE DEVELOPMENT | 30 Aug 2024 | 1,056 | 6,341 | - | - | Performance Stock Units | ||
| Teladoc Health Inc | Andrew Turitz | EVP, CORPORATE DEVELOPMENT | 30 Aug 2024 | 1,056 | 38,715 (0%) | 0% | - | Common Stock | ||
| Teladoc Health Inc | Andrew Turitz | EVP, CORPORATE DEVELOPMENT | 31 May 2024 | 3,100 | 39,286 (0%) | 0% | - | Common Stock | ||
| Teladoc Health Inc | Andrew Turitz | EVP, CORPORATE DEVELOPMENT | 31 May 2024 | 3,100 | 21,702 | - | - | Restricted Stock Units | ||
| Teladoc Health Inc | Andrew Turitz | EVP, CORPORATE DEVELOPMENT | 31 May 2024 | 1,627 | 37,659 (0%) | 0% | 11.2 | 18,152 | Common Stock | |
| Teladoc Health Inc | Andrew Turitz | EVP, CORPORATE DEVELOPMENT | 31 May 2024 | 1,348 | 36,186 (0%) | 0% | - | Common Stock | ||
| Teladoc Health Inc | Andrew Turitz | EVP, CORPORATE DEVELOPMENT | 31 May 2024 | 1,348 | 4,044 | - | - | Restricted Stock Units | ||
| Teladoc Health Inc | Andrew Turitz | EVP, CORPORATE DEVELOPMENT | 31 May 2024 | 1,056 | 7,397 | - | - | Performance Stock Units | ||
| Teladoc Health Inc | Andrew Turitz | EVP, CORPORATE DEVELOPMENT | 31 May 2024 | 1,056 | 34,838 (0%) | 0% | - | Common Stock | ||
| Teladoc Health Inc | Andrew Turitz | EVP, CORPORATE DEVELOPMENT | 19 Mar 2024 | 43,800 | 43,800 | - | - | Restricted Stock Units | ||
| Teladoc Health Inc | Andrew Turitz | EVP, CORPORATE DEVELOPMENT | 05 Mar 2024 | 5,647 | 33,782 (0%) | 0% | 14.5 | 82,051 | Common Stock | |
| Teladoc Health Inc | Andrew Turitz | EVP, CORPORATE DEVELOPMENT | 01 Mar 2024 | 12,679 | 12,679 | - | - | Performance Stock Units | ||
| Teladoc Health Inc | Andrew Turitz | EVP, CORPORATE DEVELOPMENT | 01 Mar 2024 | 12,400 | 44,471 (0%) | 0% | - | Common Stock | ||
| Teladoc Health Inc | Andrew Turitz | EVP, CORPORATE DEVELOPMENT | 01 Mar 2024 | 12,400 | 24,802 | - | - | Restricted Stock Units | ||
| Teladoc Health Inc | Andrew Turitz | EVP, CORPORATE DEVELOPMENT | 01 Mar 2024 | 6,190 | 39,429 (0%) | 0% | 14.5 | 89,854 | Common Stock | |
| Teladoc Health Inc | Andrew Turitz | EVP, CORPORATE DEVELOPMENT | 01 Mar 2024 | 4,226 | 29,419 (0%) | 0% | - | Common Stock | ||
| Teladoc Health Inc | Andrew Turitz | EVP, CORPORATE DEVELOPMENT | 01 Mar 2024 | 4,226 | 8,453 | - | - | Performance Stock Units | ||
| Teladoc Health Inc | Andrew Turitz | EVP, CORPORATE DEVELOPMENT | 01 Mar 2024 | 1,348 | 32,071 (0%) | 0% | - | Common Stock | ||
| Teladoc Health Inc | Andrew Turitz | EVP, CORPORATE DEVELOPMENT | 01 Mar 2024 | 1,348 | 5,392 | - | - | Restricted Stock Units | ||
| Teladoc Health Inc | Andrew Turitz | EVP, CORPORATE DEVELOPMENT | 01 Mar 2024 | 1,148 | 45,619 (0%) | 0% | - | Common Stock | ||
| Teladoc Health Inc | Andrew Turitz | EVP, CORPORATE DEVELOPMENT | 01 Mar 2024 | 1,148 | 0 | - | - | Restricted Stock Units | ||
| Teladoc Health Inc | Andrew Turitz | EVP, CORPORATE DEVELOPMENT | 01 Mar 2024 | 867 | 30,723 (0%) | 0% | - | Common Stock | ||
| Teladoc Health Inc | Andrew Turitz | EVP, CORPORATE DEVELOPMENT | 01 Mar 2024 | 867 | 0 | - | - | Performance Stock Units | ||
| Teladoc Health Inc | Andrew Turitz | EVP, CORPORATE DEVELOPMENT | 01 Mar 2024 | 475 | 25,193 (0%) | 0% | 15.1 | 7,154 | Common Stock | |
| Teladoc Health Inc | Andrew Turitz | EVP, CORPORATE DEVELOPMENT | 01 Mar 2024 | 437 | 29,856 (0%) | 0% | - | Common Stock | ||
| Teladoc Health Inc | Andrew Turitz | EVP, CORPORATE DEVELOPMENT | 01 Mar 2024 | 437 | 0 | - | - | Performance Stock Units | ||
| Teladoc Health Inc | Turitz Andrew | EVP, CORPORATE DEVELOPMENT | 01 Dec 2023 | 1,347 | 6,740 | - | - | Restricted Stock Units | ||
| Teladoc Health Inc | Andrew Turitz | EVP, CORPORATE DEVELOPMENT | 01 Dec 2023 | 1,347 | 26,065 (0%) | 0% | - | Common Stock | ||
| Teladoc Health Inc | Turitz Andrew | EVP, CORPORATE DEVELOPMENT | 01 Dec 2023 | 397 | 25,668 (0%) | 0% | 18.9 | 7,504 | Common Stock | |
| Teladoc Health Inc | Andrew Turitz | EVP, CORPORATE DEVELOPMENT | 01 Sep 2023 | 1,347 | 8,087 | - | - | Restricted Stock Units | ||
| Teladoc Health Inc | Andrew Turitz | EVP, CORPORATE DEVELOPMENT | 01 Sep 2023 | 1,347 | 25,114 (0%) | 0% | - | Common Stock | ||
| Teladoc Health Inc | Andrew Turitz | EVP, CORPORATE DEVELOPMENT | 01 Sep 2023 | 396 | 24,718 (0%) | 0% | 22.9 | 9,066 | Common Stock | |
| Teladoc Health Inc | Andrew Turitz | EVP, CORPORATE DEVELOPMENT | 01 Jun 2023 | 1,347 | 24,153 (0%) | 0% | - | Common Stock | ||
| Teladoc Health Inc | Andrew Turitz | EVP, CORPORATE DEVELOPMENT | 01 Jun 2023 | 1,347 | 9,434 | - | - | Restricted Stock Units | ||
| Teladoc Health Inc | Andrew Turitz | EVP, CORPORATE DEVELOPMENT | 01 Jun 2023 | 386 | 23,767 (0%) | 0% | 24.4 | 9,411 | Common Stock | |
| Teladoc Health Inc | Andrew Turitz | SVP - CORPORATE DEVELOPMENT | 03 Mar 2023 | 37,202 | 37,202 | - | - | Restricted Stock Units | ||
| Teladoc Health Inc | Andrew Turitz | SVP - CORPORATE DEVELOPMENT | 03 Mar 2023 | 1,795 | 22,806 (0%) | 0% | 25.9 | 46,510 | Common Stock | |
| Teladoc Health Inc | Andrew Turitz | SVP - CORPORATE DEVELOPMENT | 01 Mar 2023 | 5,389 | 20,183 (0%) | 0% | - | Common Stock | ||
| Teladoc Health Inc | Andrew Turitz | SVP - CORPORATE DEVELOPMENT | 01 Mar 2023 | 5,389 | 10,781 | - | - | Restricted Stock Units | ||
| Teladoc Health Inc | Andrew Turitz | SVP - CORPORATE DEVELOPMENT | 01 Mar 2023 | 2,048 | 21,635 (0%) | 0% | - | Common Stock | ||
| Teladoc Health Inc | Andrew Turitz | SVP - CORPORATE DEVELOPMENT | 01 Mar 2023 | 2,048 | 0 | - | - | Performance Stock Units | ||
| Teladoc Health Inc | Andrew Turitz | SVP - CORPORATE DEVELOPMENT | 01 Mar 2023 | 1,801 | 18,382 (0%) | 0% | 25.4 | 45,677 | Common Stock | |
| Teladoc Health Inc | Andrew Turitz | SVP - CORPORATE DEVELOPMENT | 01 Mar 2023 | 1,205 | 19,587 (0%) | 0% | - | Common Stock | ||
| Teladoc Health Inc | Andrew Turitz | SVP - CORPORATE DEVELOPMENT | 01 Mar 2023 | 1,205 | 0 | - | - | Restricted Stock Units | ||
| Teladoc Health Inc | Andrew Turitz | SVP - CORPORATE DEVELOPMENT | 01 Mar 2023 | 1,147 | 23,297 (0%) | 0% | - | Common Stock | ||
| Teladoc Health Inc | Andrew Turitz | SVP - CORPORATE DEVELOPMENT | 01 Mar 2023 | 1,147 | 1,148 | - | - | Restricted Stock Units | ||
| Teladoc Health Inc | Andrew Turitz | SVP - CORPORATE DEVELOPMENT | 01 Mar 2023 | 874 | 874 | - | - | Performance Stock Units | ||
| Teladoc Health Inc | Andrew Turitz | SVP - CORPORATE DEVELOPMENT | 01 Mar 2023 | 867 | 867 | - | - | Performance Stock Units | ||
| Teladoc Health Inc | Andrew Turitz | SVP - CORPORATE DEVELOPMENT | 01 Mar 2023 | 867 | 24,164 (0%) | 0% | - | Common Stock | ||
| Teladoc Health Inc | Andrew Turitz | SVP - CORPORATE DEVELOPMENT | 01 Mar 2023 | 515 | 22,150 (0%) | 0% | - | Common Stock | ||
| Teladoc Health Inc | Andrew Turitz | SVP - CORPORATE DEVELOPMENT | 01 Mar 2023 | 515 | 0 | - | - | Performance Stock Units | ||
| Teladoc Health Inc | Andrew Turitz | SVP - CORPORATE DEVELOPMENT | 01 Mar 2023 | 437 | 437 | - | - | Performance Stock Units | ||
| Teladoc Health Inc | Andrew Turitz | SVP - CORPORATE DEVELOPMENT | 01 Mar 2023 | 437 | 24,601 (0%) | 0% | - | Common Stock | ||
| Teladoc Health Inc | Andrew Turitz | SVP - BUSINESS DEVELOPMENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 56,430 | 56,430 | - | - | Employee Stock Option (right to buy) | |
| Teladoc Health Inc | Andrew Turitz | SVP - Business Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2022 | 2,567 | 16,128 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Andrew Turitz | SVP - Business Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2022 | 2,567 | 0 | - | - | Performance Stock Units | |
| Teladoc Health Inc | Andrew Turitz | SVP - Business Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2022 | 1,974 | 13,561 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Andrew Turitz | SVP - Business Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2022 | 1,974 | 0 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Andrew Turitz | SVP - Business Development | Sale of securities on an exchange or to another person at price $ 66.74 per share. | 04 Mar 2022 | 1,334 | 14,794 (0%) | 0% | 66.7 | 89,027 | Common Stock |
| Teladoc Health Inc | Andrew Turitz | SVP - BUSINESS DEVELOPMENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 2,602 | 2,602 | - | - | Performance Stock Units | |
| Teladoc Health Inc | Andrew Turitz | SVP - BUSINESS DEVELOPMENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2022 | 2,050 | 2,048 | - | - | Performance Stock Units | |
| Teladoc Health Inc | Andrew Turitz | SVP - BUSINESS DEVELOPMENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2022 | 2,050 | 10,811 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Andrew Turitz | SVP - BUSINESS DEVELOPMENT | Sale of securities on an exchange or to another person at price $ 70.24 per share. | 02 Mar 2022 | 1,754 | 11,587 (0%) | 0% | 70.2 | 123,199 | Common Stock |
| Teladoc Health Inc | Andrew Turitz | SVP - BUSINESS DEVELOPMENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2022 | 1,205 | 8,761 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Andrew Turitz | SVP - BUSINESS DEVELOPMENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2022 | 1,205 | 1,205 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Andrew Turitz | SVP - BUSINESS DEVELOPMENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2022 | 1,147 | 2,295 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Andrew Turitz | SVP - BUSINESS DEVELOPMENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2022 | 1,147 | 12,473 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Andrew Turitz | SVP - BUSINESS DEVELOPMENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 1,030 | 1,030 | - | - | Performance Stock Units | |
| Teladoc Health Inc | Andrew Turitz | SVP - BUSINESS DEVELOPMENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2022 | 868 | 1,734 | - | - | Performance Stock Units | |
| Teladoc Health Inc | Andrew Turitz | SVP - BUSINESS DEVELOPMENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2022 | 868 | 13,341 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Andrew Turitz | SVP - BUSINESS DEVELOPMENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2022 | 515 | 515 | - | - | Performance Stock Units | |
| Teladoc Health Inc | Andrew Turitz | SVP - BUSINESS DEVELOPMENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2022 | 515 | 11,326 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Andrew Turitz | SVP - Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 16,170 | 16,170 | - | - | Restricted Stock Units |